2020-06-19T05:50:30-05:00 2019-12-31 410746749 CLIFTONLARSONALLEN LLP 610 W GERMANTOWN PIKE SUITE 400 PLYMOUTH MEETING PA 19462 990 2019-01-01 223369741 INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH INTE 6095864981 505 LAWRENCE SQUARE BLVD SOUTH LAWRENCEVILLE NJ 08648 MS NANCY S BERG CEO & EXECUTIVE DIRECTOR 6095864981 2020-06-17 1 WILLIAM A LOUGHERY P01603932 2156433900 2020-06-17 67.137.57.251 2020-06-17 13:59:31 ED P 48DF7E18B51ED0D4ADE189227F60937B8E503023 BDA8042A4A1B5EFC7B6B23756E4A8DE2138A36D7 2019 2021-01-29 14:40:06Z MS NANCY S BERG 505 LAWRENCE SQUARE BLVD SOUTH LAWRENCEVILLE NJ 08648 19100487 0 X WWW.ISPOR.ORG X 1995 NJ PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY 12 11 53 750 50660 7372 904564 210000 14812023 15953983 523000 347895 42672 47948 16282259 16559826 0 0 0 0 5846841 6404867 0 0 0 8926993 8709738 14773834 15114605 1508425 1445221 17365453 20352941 1982231 2402976 15383222 17949965 X THE MISSION OF ISPOR IS TO PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY. 0 0 12832087 0 15903323 ISPOR IS A NON-PROFIT GLOBAL SCIENTIFIC AND EDUCATIONAL ORGANIZATION WITH APPROXIMATELY 8,650 MEMBERS, WHO ARE INVOLVED IN HEALTHCARE OUTCOMES RESEARCH (INCLUDING CLINICAL, ECONOMIC AND PATIENT-REPORTED OUTCOMES) OF HEALTH TECHNOLOGIES (DRUGS, DEVICES, DIAGNOSTICS) AND SERVICES OR THE USE OF OUTCOMES RESEARCH IN HEALTHCARE DECISIONS. THE MISSION OF ISPOR IS TO PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY. ISPOR IS FUNDED THROUGH ITS MEETINGS, TRAINING COURSES AND MEMBERSHIP DUES. THROUGH ITS MULTIPLE MEETINGS EACH YEAR, ISPOR PROVIDES A FORUM TO FACILITATE THE INTERCHANGE OF SCIENTIFIC KNOWLEDGE IN PHARMACOECONOMICS/HEALTH ECONOMICS AND OUTCOMES RESEARCH, HEALTH POLICYAND THE USE OF THIS RESEARCH IN HEALTHCARE DECISIONS. ISPOR PUBLISHES TWO SCIENTIFIC JOURNALS, ONE TECHNICAL AND NEWS JOURNAL, AND FOUR ELECTRONIC NEWSLETTERS. ISPOR DEVELOPS CONSENSUS DOCUMENTS (GOOD PRACTICES/GUIDELINES) ON OUTCOMES RESEARCH METHODS OR USE OF THIS RESEARCH IN HEALTHCARE DECISIONS. ISPOR FOSTERS EDUCATION AND THE DEVELOPMENT OF OUTCOMES RESEARCH AT THE LOCAL LEVEL WITH ITS REGIONAL CHAPTERS AND STUDENT CHAPTERS GLOBALLY TO PROMOTE THE SCIENCE OF PHARMACOECONOMICS/HEALTH ECONOMICS AND HEALTH OUTCOMES RESEARCH WORLDWIDE. ISPOR HELD FOUR CONFERENCES IN 2019 (WARSAW, NEW ORLEANS, BOGOTA, AND COPENHAGEN) INCLUDING 5,000 SCIENTIFIC PRESENTATIONS WITH OVER 10,000 PARTICIPANTS. IN 2019, ISPOR PUBLISHED 3,248 PAGES OF OUTCOMES RESEARCH AND HEALTH POLICY PAPERS IN ITS THREE JOURNALS: VALUE IN HEALTH, VALUE IN HEALTH REGIONAL ISSUES AND VALUE AND OUTCOMESSPOTLIGHT. IN 2019 ISPOR HAD OVER 8,650 MEMBERS FROM 110 COUNTRIES, 128 STUDENTS AND OVER 85 REGIONAL CHAPTERS AROUND THE WORLD. THROUGH ISPOR TASK FORCES, COUNCILS AND SPECIAL INTEREST GROUPS, ISPOR HAS DEVELOPED 'TOOLS' FOR OUTCOMES RESEARCHERS, SUCH AS GOOD PRACTICES FOR OUTCOMES RESEARCH WITH OVER 1,000,000 DOWNLOADS ANNUALLY AND A WEB-BASED DATABASE OF OVER 50,000 RESEARCH PRESENTATIONS GIVEN AT ISPOR MEETINGS. 12832087 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 95 0 53 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 12 11 0 0 0 0 1 1 0 1 1 0 1 1 0 1 1 1 1 1 1 0 0 NJ X KEVIN DOLAN 6095864981 505 LAWRENCE SQUARE BLVD SOUTH LAWRENCEVILLE NJ 08648 SHELBY D REED PAST PRESIDENT (LEFT JUNE 2019) 2.00 X X 0 0 0 FEDERICO AUGUSTOVSKI PAST PRESIDENT 2.00 X X 0 0 0 NANCY DEVLIN PRESIDENT 2.00 X X 0 0 0 JENS GRUEGER PRESIDENT - ELECT (2019-2020) 2.00 X X 0 0 0 ZEBA M KHAN TREASURER 2.00 X X 0 0 0 NANCY S BERG CEO & EXECUTIVE DIRECTOR 40.00 X X 498602 0 56526 MEINDERT BOYSEN DIRECTOR 2.00 X 0 0 0 STEPHANIE EARNSHAW DIRECTOR 2.00 X 0 0 0 JAN ELIAS HANSEN DIRECTOR 2.00 X 0 0 0 JOHN WATKINS DIRECTOR (LEFT JUNE 2019) 2.00 X 0 0 0 JALPA DOSHI DIRECTOR 2.00 X 0 0 0 ROK HREN DIRECTOR 2.00 X 0 0 0 RAOH-FANG PWU DIRECTOR 2.00 X 0 0 0 NEIL HAWKINS DIRECTOR 2.00 X 0 0 0 KEVIN DOLAN DIRECTOR, FINANCE 40.00 X 133114 0 20055 SUSAN CAPON CHIEF OPERATING OFFICER 40.00 X 322039 0 49244 LUCINDA ORSINI ASSOCIATE CHIEF SCIENCE OFFICER 40.00 X 269337 0 27635 CHRISTINA DARNOWSKI DIRECTOR, GOVERNANCE 40.00 X 225886 0 46127 ELIZABETH LANE CHIEF MARKETING OFFICER 40.00 X 151584 0 39334 NADIA NAAMAN SENIOR DIRECTOR 40.00 X 129577 0 31861 JENNIFER OLSEN-CASILLAS DIRECTOR, MEMBER SERVICES 40.00 X 169053 0 40890 1899192 0 311672 10 0 1 0 BELLA CENTER HOSPITALITY GROUP CENTER BOULEVARD 5 COPENHAGEN DA MEETING EXPENSES 1701188 ELSEVIER INC PO BOX 9533 NEW YORK NY 100879533 PUBLISHING 525688 SERVICE AMERICA CORPORATION 900 CONVENTION CENTER BLVD NEW ORLEANS LA 70130 CATERING 516481 RICHARD J WILLKE 11622 CHANNEL FRONT COURT SODDY DAISY TN 37379 SCIENTIFIC CONSULTING 372266 FREEMAN COMPANIES PO BOX 650036 DALLAS TX 752650036 EXHIBITS 239315 14 210000 210000 ANNUAL EUROPEAN MEETING 561920 7948623 7944623 4000 ANNUAL MEETING 561920 4383502 4380002 3500 JOURNAL 900099 1164203 1164203 BIENNIAL MEETINGS 900099 950422 950422 MEMBER SERVICES 900099 890825 890825 616408 573248 43160 15953983 333472 333472 69340 21392 47948 47948 47948 2533692 2519269 14423 14423 14423 16559826 15903323 50660 395843 1079530 333077 746453 4078753 3411915 666838 436478 369676 66802 467097 355472 111625 343009 252942 90067 46046 3845 42201 26700 26700 76559 76559 936873 924315 12558 412240 303995 108245 106698 78681 28017 217311 217311 3742771 3742771 217662 160509 57153 39112 28842 10270 TAX EXPENSE 2656 2656 JOURNAL/EDITORIAL 1034434 1034434 BOARD/COMMITTEE EXPENSE 932571 932571 BANK/CREDIT CARD FEES 365096 269229 95867 553009 412502 140507 15114605 12832087 2282518 0 1106343 884582 3650609 2262063 531158 691778 328925 397565 4174443 854299 3168386 3320144 8518119 12796809 61913 17365453 20352941 1192722 574175 762569 1806410 26940 22391 1982231 2402976 X 15383222 17949965 15383222 17949965 17365453 20352941 1445221 1121522 0 X 0 1 X 1 0 X 800701 786327 912462 904564 210000 3614054 10098343 11578131 13823398 14730663 15903323 66133858 10899044 12364458 14735860 15635227 16113323 69747912 0 0 0 69747912 290023 317484 306961 341347 402812 1658627 290023 317484 306961 341347 402812 1658627 8398 97279 66192 10586 7372 189827 11197465 12779221 15109013 15987160 16523507 71596366 0.97420 0.70730 0.02320 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 400000 400000 2535060 465374 2069686 1239383 388925 850458 3320144 SECURITY DEPOSIT 7391 MISCELLANEOUS DEPOSIT 15000 22391 X 17604789 1121522 1121522 16483267 76559 76559 16559826 15038046 0 15038046 76559 76559 15114605 PART X, LINE 2: ISPOR IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). HOWEVER, INCOME FROM CERTAIN ACTIVITIES NOT DIRECTLY RELATED TO ISPOR'S TAX-EXEMPT PURPOSE IS SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. ISPOR FOLLOWS THE INCOME TAX STANDARD FOR UNCERTAIN TAX POSITIONS. ISPOR BELIEVES THERE ARE NO UNCERTAIN TAX POSITIONS THAT ARE REQUIRED TO BE DISCLOSED IN THE FINANCIAL STATEMENTS. EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 30 PROGRAM SERVICE ANNUAL EUROPEAN MEETING 2073757 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 4 PROGRAM SERVICE BIENNIAL MEETING 74483 EUROPE (INCLUDING ICELAND & GREENLAND) 0 2 PROGRAM SERVICE SCIENTIFIC CONSULTING 275315 SOUTH AMERICA 0 10 PROGRAM SERVICE REGIONAL EVENT MEETING 433865 0 46 0 0 0 46 2857420 0 2857420 0 0 0 0 0 0 PART III ACCOUNTING METHOD: X X X X X 0 0 0 0 0 0 0 1 0 NANCY S BERG CEO & EXECUTIVE DIRECTOR 418175 0 80427 0 0 0 42000 0 14526 0 555128 0 0 0 KEVIN DOLAN DIRECTOR, FINANCE 125764 0 6350 0 1000 0 20055 0 0 0 153169 0 0 0 SUSAN CAPON CHIEF OPERATING OFFICER 207813 0 114226 0 0 0 37000 0 12244 0 371283 0 0 0 LUCINDA ORSINI ASSOCIATE CHIEF SCIENCE OFFICER 245337 0 24000 0 0 0 15391 0 12244 0 296972 0 0 0 CHRISTINA DARNOWSKI DIRECTOR, GOVERNANCE 154723 0 71163 0 0 0 33883 0 12244 0 272013 0 0 0 ELIZABETH LANE CHIEF MARKETING OFFICER 143991 0 7593 0 0 0 24808 0 14526 0 190918 0 0 0 NADIA NAAMAN SENIOR DIRECTOR 123519 0 6058 0 0 0 19617 0 12244 0 161438 0 0 0 JENNIFER OLSEN-CASILLAS DIRECTOR, MEMBER SERVICES 117371 0 51682 0 0 0 26882 0 14008 0 209943 0 0 0 PART I, LINE 7 THE FOLLOWING EMPLOYEES RECEIVED BONUSES IN 2019: NANCY BERG: $80,427 BONUS BASED ON CONTRACTUAL TERMS AS APPROVED BY THE EXECUTIVE COMMITTEE, AND DETERMINED BASED ON FACTORS SUCH AS PERSONAL PERFORMANCE GOALS AND ISPOR'S BUDGET PERFORMANCE. THE MAXIMUM BONUS ALLOWABLE IS 25% OF BASE SALARY. KEVIN DOLAN: $6,350 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. SUSAN CAPON: $114,226 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. LUCINDA ORSINI: $24,000 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. CHRISTINA DARNOWSKI: $71,163 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. ELIZABETH LANE: $7,593 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. NADIA NAAMAN: $6,058 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. JENNIFER OLSEN-CASILLAS: $51,682 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. THE BONUSES WERE PART OF THE ANNUAL BUDGET WHICH WAS APPROVED BY THE BOARD OF DIRECTORS. THESE AMOUNTS ARE INCLUDED IN EACH RECIPIENT'S 2019 FORM W-2. FORM 990, PART VI, SECTION A, LINE 1 THE EXECUTIVE COMMITTEE HAS THE DUTIES AND AUTHORITY BETWEEN MEETINGS OF THE BOARD, IN PLACE OF THE BOARD, TO TAKE ACTION ON MATTERS CONSISTENT WITH THE GOALS OF THE SOCIETY. THE EXECUTIVE COMMITTEE IS COMPRISED OF THE OFFICERS OF THE SOCIETY: PRESIDENT, IMMEDIATE PAST PRESIDENT, PRESIDENT-ELECT, EXECUTIVE DIRECTOR (AS SECRETARY) AND TREASURER. THE EXECUTIVE DIRECTOR IS A VOTING MEMBER OF THE BOARD, EXCEPT ON THE MATTER OF THE EXECUTIVE DIRECTOR'S SALARY AND CONTRACT REVIEW AND DETERMINATION. FORM 990, PART VI, SECTION A, LINE 6 THE SOCIETY HAS THREE TYPES OF MEMBERS AS FOLLOWS: MEMBER - ANY INDIVIDUAL WHO SUPPORTS THE OBJECTIVES OF THE SOCIETY AND IS WILLING TO CONTRIBUTE TO THE ACHIEVEMENT OF THOSE OBJECTIVES IS ELIGIBLE FOR MEMBERSHIP. STUDENT MEMBER - ANY INDIVIDUAL FORMALLY ENROLLED IN A PROGRAM OF STUDY WHICH INCLUDES ASPECTS OF HEALTH ECONOMICS OR HEALTH OUTCOMES RESEARCH IN THE STUDY CURRICULUM AND SUPPORTS THE MISSION OF THE SOCIETY IS ELIGIBLE FOR STUDENT MEMBERSHIP. FELLOW - ANY MEMBER WHO IS DEEMED TO HAVE MADE A MERITORIOUS CONTRIBUTION TO THE ADVANCEMENT OF HEALTH ECONOMICS AND/OR OUTCOMES RESEARCH AS DEFINED BY THE ISPOR BOARD. THE BOARD OF DIRECTORS MAY, IN THE INTERESTS OF THE SOCIETY, ESTABLISH OTHER CLASSES OF MEMBERSHIP. FORM 990, PART VI, SECTION A, LINE 7A MEMBERS, STUDENT MEMBERS AND FELLOWS HAVE THE RIGHT VOTE FOR BOARD OFFICERS AND DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B THE ISPOR FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM. THE REVIEW OF THE FORM 990 BEFORE FILING IS DELEGATED TO THE CEO AND EXECUTIVE DIRECTOR BY THE BOARD OF DIRECTORS. THE COMPLETED FORM 990 IS AVAILABLE FOR REVIEW BY THE BOARD OF DIRECTORS AND THE MEMBERSHIP AFTER FILING. FORM 990, PART VI, SECTION B, LINE 12C TO INSURE COMPLIANCE WITH THE ORGANIZATION'S CONFLICT OF INTEREST POLICY, BOARD MEMBERS, OFFICERS AND EMPLOYEES AGREE TO COMPLY WITH THE POLICY BY COMPLETING AND SIGNING A CONFLICT OF INTEREST STATEMENT. EVERY YEAR THE BOARD HAS THE RESPONSIBILITY OF ENSURING COMPLIANCE WITH THE POLICY, ADMINISTERING THE ANNUAL QUESTIONNAIRE AND MAKING DECISIONS AS REQUIRED TO AVOID ACTUAL CONFLICT OF INTEREST. THE BOARD ALSO REVIEWS AND REVISES THIS POLICY AS NEEDED IN THE EVENT OF AN ACTUAL CONFLICT OF INTEREST OR THE APPEARANCE OF A CONFLICT OF INTEREST, INTERESTED PARTY MUST DISCLOSE THE NATURE OF THE CONFLICT AND HE/SHE SHALL NOT BE PRESENT IN THE BOARD OR COMMITTEE DELIBERATIONS OR VOTE ON THE MATTER. COMPLETED CONFLICT OF INTEREST FORMS ARE INCLUDED ON BOARD AGENDAS, AND RECORDED IN THE BOARD MINUTES. FORM 990, PART VI, SECTION B, LINE 15A THE EXECUTIVE COMMITTEE, EXCLUDING THE EXECUTIVE DIRECTOR, CONDUCTS AN ANNUAL REVIEW OF THE EXECUTIVE DIRECTOR'S PERFORMANCE INCLUDING ACCOMPLISHMENTS VERSUS PRE-SPECIFIED GOALS AS WELL AS THE PERFORMANCE OF THE ORGANIZATION. BENCHMARKING OF THE COMPENSATION OF THE EXECUTIVE DIRECTOR IS DETERMINED USING ASSOCIATION CHIEF STAFF EXECUTIVE COMPENSATION SURVEYS BY THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVES (ASAE). COMPENSATION OF THE EXECUTIVE DIRECTOR IS ALSO DETERMINED WITH THE USE OF COMPENSATION SURVEYS AND FORMS 990 OF SIMILAR ORGANIZATIONS. IN ADDITION, IN 2017, THE EXECUTIVE COMMITTEE HIRED AN EXECUTIVE SEARCH FIRM TO PROVIDE COMPENSATION ADVICE FOR THE EXECUTIVE DIRECTOR'S COMPENSATION. A LETTER FROM THE PRESIDENT AUTHORIZING THE EXECUTIVE DIRECTOR'S COMPENSATION IS RETAINED WITH THE ISPOR PAYROLL RECORDS. FORM 990, PART VI, SECTION C, LINE 18 ISPOR MAKES ITS FORM 990 AVAILABLE FOR PUBLIC INSPECTION AS REQUIRED UNDER SECTION 6104 OF THE INTERNAL REVENUE CODE. THE RETURN IS POSTED ON GUIDESTAR.ORG AND OTHER SIMILAR TYPES OF WEBSITES. IN ADDITION, THE FORM 990 AND FORM 1023 ARE ALSO AVAILABLE UPON WRITTEN REQUEST AT ISPOR'S ADDRESS. FORM 990, PART VI, SECTION C, LINE 19 ISPOR MAKES ITS FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS AVAILABLE UPON WRITTEN REQUESTS SUBMITTED TO ISPOR'S ADDRESS.